comparemela.com

Latest Breaking News On - Shane storey - Page 1 : comparemela.com

Wilsons Sticks to Its Hold Rating for Next Science Ltd (NXSCF)

In a report released on January 31, Shane Storey from Wilsons maintained a Hold rating on Next Science Ltd (NXSCF – Research Report), with.

Telix pharmaceuticals ltdScience ltdShane storeyNext science ltdResearch reportNanosonics limited

Is the worst over for ResMed shares?

Is the worst over for ResMed shares?
fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.

Bell potterGoldman sachsHarvard healthResmed incShane storey

Why is everyone talking about Resmed shares and Ozempic?

Why is everyone talking about Resmed shares and Ozempic?
fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.

Bell potterMichael sarconeMatthew taylorMick farrellYoung liResmed incInvestments commissionAustralian securitiesShane storeyAustralian financial review

Positive Report for Next Science Ltd (NXSCF) from Wilsons

Wilsons analyst Shane Storey upgraded Next Science Ltd (NXSCF – Research Report) to a Buy today and set a price target of A$0.57. The comp.

Telix pharmaceuticals ltdScience ltdShane storeyNext science ltdResearch reportModerate buySurgx sterileBactisure surgical lavageBlastx wound

Wilsons Keeps Their Hold Rating on Next Science Ltd (NXSCF)

Wilsons analyst Shane Storey maintained a Hold rating on Next Science Ltd (NXSCF – Research Report) on July 28 and set a price target of A.

Telix pharmaceuticals ltdRamsay health careResearch report onScience ltdShane storeyNext science ltdResearch reportImpedimed limitedRamsay healthModerate buySurgx sterileBactisure surgical lavageBlastx wound

vimarsana © 2020. All Rights Reserved.